Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Rejection in Kidney Transplant”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Looking for participantsNCT06552169
What this trial is testing

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

Who this might be right for
Kidney Transplantation
Singulera Therapeutics Inc. 34
Post-approval studies (Phase 4)Study completedNCT01820897
What this trial is testing

Efficacy of Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney Transplantation

Who this might be right for
Urinary Tract InfectionAsymptomatic BacteriuriaAllograft Rejection+2 more
JOSE MANUEL ARREOLA GUERRA 130
Testing effectiveness (Phase 2)Study completedNCT00670774
What this trial is testing

Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant

Who this might be right for
Kidney Transplant
Mark Stegall 31
Large-scale testing (Phase 3)Not Yet RecruitingNCT07835581
What this trial is testing

Phase 3 Randomized Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation

Who this might be right for
Kidney Transplant Rejection
Eledon Pharmaceuticals 620
Testing effectiveness (Phase 2)WithdrawnNCT00556257
What this trial is testing

Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Pfizer
Testing effectiveness (Phase 2)Study completedNCT04046549
What this trial is testing

Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

Who this might be right for
AllograftsRejection; Transplant, KidneyTransplant Rejection+1 more
Amgen 25
Testing effectiveness (Phase 2)Looking for participantsNCT05027906
What this trial is testing

Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant

Who this might be right for
Prevention of Rejection in Kidney Transplant
Eledon Pharmaceuticals 48
Post-approval studies (Phase 4)Study completedNCT02377193
What this trial is testing

Simulect Versus ATG in Sensitized Renal Transplant Patient

Who this might be right for
Renal Transplant Rejection
University Hospital, Toulouse 60
Large-scale testing (Phase 3)Study completedNCT00147381
What this trial is testing

Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection

Who this might be right for
Kidney Transplantation
Dr. Claudia Bösmüller 197
Large-scale testing (Phase 3)Study completedNCT02091414
What this trial is testing

CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.

Who this might be right for
Heart Transplantation
Hoffmann-La Roche 36
Testing effectiveness (Phase 2)Study completedNCT00658359
What this trial is testing

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Pfizer 178
Testing effectiveness (Phase 2)Study completedNCT00106639
What this trial is testing

A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Pfizer 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT05156710
What this trial is testing

BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)

Who this might be right for
Transplant Rejection
Sanofi 48
Testing effectiveness (Phase 2)Study completedNCT01536379
What this trial is testing

Belimumab in the Prevention of Kidney Transplant Rejection

Who this might be right for
Transplantation, Organ
GlaxoSmithKline 30
Post-approval studies (Phase 4)Study completedNCT00656695
What this trial is testing

Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation

Who this might be right for
End Stage Renal DiseaseRenal Transplantation
Imam Khomeini Hospital 208
Post-approval studies (Phase 4)Study completedNCT02554955
What this trial is testing

Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant Participants

Who this might be right for
Heart Transplantation
Hoffmann-La Roche 36
Large-scale testing (Phase 3)Study completedNCT00565331
What this trial is testing

Rituximab for Prevention of Rejection After Renal Transplantation

Who this might be right for
Kidney Transplantation
Radboud University Medical Center 280
Large-scale testing (Phase 3)Study completedNCT01544491
What this trial is testing

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Who this might be right for
Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant
Novartis Pharmaceuticals 106
Testing effectiveness (Phase 2)Looking for participantsNCT07053462
What this trial is testing

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Who this might be right for
End-Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd Stage Renal Disease With Renal Transplant+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Post-approval studies (Phase 4)Study completedNCT00118742
What this trial is testing

Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Who this might be right for
Liver Transplantation
Hoffmann-La Roche 293
Next Page